Methods: We retrospectively evaluated BMD changes for 197 consecutive patients with thoracic
esophageal cancer who were disease-free for 5 years after radical
esophagectomy.
Osteoporosis was diagnosed using computed tomography with an L1 attenuation threshold of ≤110 HU. Survival analysis was performed on 381 consecutive patients with 5-year follow-up after radical
esophagectomy.
Results: BMD decreased annually after
esophagectomy. The median attenuation (HU) was 134.2 before surgery and 135.2, 127.4, 123.3, 115.2, 105.6, and 102.4 at 6 months and 1, 2, 3, 4, and 5 years after surgery, respectively.
Osteoporosis was diagnosed in 25.9% patients before surgery and 23.3%, 29.4%, 40.1%, 46.7%, 54.8%, and 60.4% patients with
osteoporosis were observed at 6 months and 1, 2, 3, 4, and 5 years after surgery, respectively. Postoperative BMD did not decrease in patients aged ≤54 years, those who had never been smokers, and those with no
weight loss after
esophagectomy. Multivariate analysis identified that age (≥65 years) at surgery and smoking history were independent risk factors for
osteoporosis at 5 years after
esophagectomy. Patients with preoperative
osteoporosis tended to have worse prognosis in disease-free survival and overall survival than those without
osteoporosis, who were more likely to die due to non-
esophageal cancer.
Conclusion: